Quick Stats

Quick Stats

    You are here

    FDA Establishes Tobacco Committee

    Group will identify impact of menthol use in cigarettes, advise applications for "modified risk" tobacco products and more.

    WASHINGTON -- In its implementation of the Family Smoking Prevention and Tobacco Control Act, legislation giving the U.S. Food and Drug Administration (FDA) power to regulate the tobacco industry, the organization established the Tobacco Products Scientific Advisory Committee (TPSAC).

    The TPSAC will provide advice, information and recommendations to the commissioner of Food and Drugs on health and other issues relating to tobacco products, the FDA stated. The committee will also identify the effects nicotine yield alternation in tobacco products; research the impact of menthol’s use in cigarettes; and advise applications for modified risk, such as the descriptor "light," on tobacco products.

    The TPSAC will consist of 12 members, including a chair who will be selected by the commissioner of Food and Drugs. There will be nine voting and three non-voting members, and of the nine voting members, seven will be health care professionals. One member will be an officer or employee of a state, local government or the federal government, and the final member will be a representative of the general public, the FDA stated.

    The three non-voting members will be identified with industry interests, including one representative of the tobacco manufacturing industry, one from tobacco growers and one from the small business manufacturing industry, according to the FDA.

    Related News:

    FDA Names Tobacco Chief

    Blazing a New Tobacco Road

    • About

    Related Content

    Related Content